De Pardieu has advised Acteon Group, a leading manufacturer of dental products and medical devices and majority stake of the family investment holding company DENTRESSANGLE, on the signing of an agreement with Septodont, a French pharmaceutical and medical devices company, to become shareholders of Inibsa, a Spanish-based pharmaceutical group specializing in the manufacture of products for dental practitioners.

Septodont will be the controlling shareholder of Inibsa, while Acteon Group will be a partner and reference shareholder, aiming to secure and develop the existing supply relationship with the Spanish laboratory. Septodont will hold 51% of the shares, while the remaining 49% will be held by Acteon Group.